• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

LeVerage LFS

November 1, 2025 By SPINEMarketGroup

LeVerage LFS is intended for use in the lower cervical and upper thoracic spine (C3 to T3) in laminoplasty procedures. LeVerage LFS is used to hold the allograft material in place in order to prevent the allograft material from expulsion, or impinging the spinal cord. Leverage LFS implants are made from titanium alloy. This material was selected for its stability, corrosion resistance and strong mechanical properties. Long-term clinical experience of the use of this material has shown that an acceptable level of biological response can be expected, if the material is used in appropriate applications.

  • LeVerage LFS Laminoplasty-SGT.Nuvasive.pdf
  • LeVerage LFS VIDEO ANIMATION

About Nuvasive

NuVasive, Inc. (NASDAQ: NUVA) based in San Diego, California, is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. NuVasive’s product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company’s current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS, as well as a growing offering of cervical and motion preservation products. NuVasive® is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine.

The Company is the third largest medical device company in the $8.2 billion global spine market. NuVasive’s principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches.

With over 90 products today spanning lumbar, thoracic and cervical applications, the Company will continue to expand and evolve its offering predicated on its R&D focus. http://www.nuvasive.com

About Globus Medical

Globus Medical, Inc. is a leading musculoskeletal solutions company and is driving significant technological advancements across a complete suite of products. Founded in 2003, Globus’ single-minded focus on advancing surgery has made it the fastest growing company in the history of orthopedics. Globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients. Additional information can be accessed at www.globusmedical.com.

Related Posts:

  • (UPDATED 2025): +30 Laminoplasty Plates to Know..!
  • Sartori Laminoplasty Fixation System
  • TARDIS™ Laminoplasty System

Filed Under: Laminoplasty Plates

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • BROCHURES
  • Globus Medical: Stronger in Spine, but Could DePuy…
  • PRODUCT LIBRARY
  • Who Is Really Winning the Mid-Tier Spine…
  • Globus Medical’s Strategy: Building a Closed-Loop…
  • Why Spine’s Commercial Model Needs a Reset? The real…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • What Is Medtronic’s PILAR™ Technique?
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • Johnson & Johnson Explores Potential $20B Sale…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • COMPANIES
  • Globus Medical Reports Fourth Quarter and Full Year…
  • From Niche to Momentum: The Rapid Rise of Spinal…
  • Single-Use Spine Surgery Systems: The Future or…
  • Behind the Deal: The Strategic Logic of Zavation’s…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • BoxSPINE Receives FDA Clearance for Rodless Spinal…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • Orthofix Realigns Spine Leadership to Strengthen…
  • Expandable cages were adopted not because they fused…
  • VB Spine Announces Successful First Clinical Cases…
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • From Early Innovations to Modern Practice: Where Are…
  • VB Spine Announces VB Spine Solutions, a…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • ATEC’s Valence: Robotics in Service of a Procedural Strategy
  • Globus Medical Reports First Quarter 2026 Results
  • LAST 5 VIDEOS PUBLISHED

    1. REACH Medical: Expandable PLIF/TLIF Cage
    2. Expanding Innovations: X-PAC®TLIF 
    3. SI-BONE: iFuse INTRA Ti™ Implant System
    4. Globus Medical: IntraLIF™ Cannulated
    5. SI-BONE: iFuse TORQ TNT® Implant System

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup